Trial Profile
Clinical Trials Insight: 700030422
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 07 Feb 2008
Price :
$35
*
At a glance
- Drugs Nalbuphine (Primary)
- Indications Musculoskeletal pain; Osteoarthritis
- Focus Therapeutic Use
- Sponsors Penwest Pharmaceuticals
- 07 Feb 2008 New trial record.